Salarius Pharmaceuticals, Inc. (SLRX)
NASDAQ: SLRX · Real-Time Price · USD
0.7265
+0.0265 (3.79%)
At close: Apr 2, 2025, 4:00 PM
0.6984
-0.0281 (-3.87%)
After-hours: Apr 2, 2025, 7:40 PM EDT

Salarius Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2016 - 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2019
Market Capitalization
13332222
Upgrade
Market Cap Growth
3.58%3.58%-26.56%-84.44%3.42%41.29%
Upgrade
Enterprise Value
-1-0-5-13-913
Upgrade
Last Close Price
0.731.845.2012.2499.12182.00
Upgrade
PS Ratio
---12.184.14
Upgrade
PB Ratio
0.691.750.480.340.580.98
Upgrade
P/TBV Ratio
1.751.750.480.340.751.63
Upgrade
EV/Sales Ratio
----2.46
Upgrade
Debt / Equity Ratio
0.150.150.06--0.02
Upgrade
Asset Turnover
----0.060.27
Upgrade
Quick Ratio
1.611.614.543.2213.845.40
Upgrade
Current Ratio
1.981.985.023.4014.295.70
Upgrade
Return on Equity (ROE)
-164.02%-164.02%-160.07%-128.73%-41.94%-44.91%
Upgrade
Return on Assets (ROA)
-74.59%-74.59%-75.90%-51.76%-24.35%-25.07%
Upgrade
Return on Capital (ROIC)
-98.05%-98.05%-100.98%-58.48%-26.10%-28.86%
Upgrade
Earnings Yield
-439.64%-210.27%-489.95%-906.79%-56.99%-33.94%
Upgrade
FCF Yield
-356.81%-170.66%-501.81%-504.79%-45.53%-47.61%
Upgrade
Buyback Yield / Dilution
-135.79%-135.79%-53.66%-28.40%-165.53%-376.61%
Upgrade
Updated Mar 21, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q